Summary
In order to elucidate the phase specificity of the embryo-lethal and teratogenic action of actinomycin D (day 5–10 of gestation) rats received 3H-actinomycin D at different times of gestation. The distribution of the radioactivity in the fetus and the placenta was measured. Moreover, the effects of actinomycin D on the RNA polymerase reactions in isolated nuclei of the decidual and fetal tissue were studied. The biochemical results were correlated electron microscopically with specific alterations occurring in different structures of the total implantation sites.
These studies show that the time-dependent embryo-lethal and teratogenic effects of actinomycin D result from a lesion of the embryo and the decidua. The effects of the decidua occur at an earlier time and are more pronounced as compared to those of the embryo. Since the decidua is significant for the nutrition of the embryo till closure of the yolk-sac and beginning of the yolk-sac circulation (day 10 of gestation), the direct effects of actinomycin D on the embryo are intensified by the lesion of the decidua. After day 10 of gestation till the beginning of the placental function 3H-actinomycin D passes over to the embryo. But the concentration-even after a dose of 1 mg/kg-does not suffice to inhibit in vivo RNA polymerase reactions in isolated nuclei.
Similar content being viewed by others
References
Burton, K.: A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62, 315 (1956).
Carpent, G., Desclin, L. M.: A propos du méchanisme d'action de l'actinomycine D sur la gestation chez le rat. R. C. Acad. Sci. (Paris) 264, 2933–2936 (1967).
David, H.: Zum Verhalten von granulärem endoplasmatischem Retikulum, Polysomen und Ribosomen in der Leber nach Actinomycingaben. Verh. anat. Ges. (Jena) 125, 223–227 (1969).
Dingman, C. W., Sporn, M. B.: Actinomycin D and hydrocortisone: intracellular binding in rat liver. Science 149, 1215–1254 (1965).
Flickinger, C. I.: The fine structure of the nucleoli of normal and Actinomycin D-treated Amoeba proteus. J. Ultrastruct. Res. 23, 260–271 (1968).
Goldberg, I. H., Reich, E.: Actinomycin inhibition of RNA synthesis directed by DNA. Fed. Proc. 23, 958–964 (1964).
Goldblatt, P. I., Verbin, R. S., Sullivan, R. I.: Induction of nucleolar segregation by Actinomycin D following inhibition of protein synthesis with cycloheximide. Exp. Cell Res. 63, 117–123 (1970).
Honig, G. R., Rabinowitz, M.: Actinomycin D: Inhibition of protein synthesis unrelated to effect on template RNA synthesis. Science 149, 1504–1506 (1965).
Jordan, R. L., Wilson, J. G.: Radioautographic study of RNA synthesis in normal and Actinomycin D-treated rat embryos. Anat. Rec. 168, 549–564 (1970).
Köhler, E., Merker, H.-J., Ehmke, W., Wojnorowicz, F.: Growth kinetics of mammalian embryos during the stage of differentiation. Naunyn-Schmiedebergs Arch. Pharmakol. 272, 169–181 (1972).
Levinthal, C., Keynan, A., Higa, A.: Messenger RNA turnover and protein synthesis in B. subtilis inhibited by actinomycin D. Proc. nat. Acad. Sci. (Wash.) 48, 1631–1638 (1962).
Merker, H.-J., Villegas, H.: Elmiuntersuchungen zum Problem des Stoffaustausches zwischen Mutter und Keim bei Rattenembryonen des Tages 7–10. Z. Anat. Entwickl.-Gesch. 131, 325–346 (1970).
Reich, E., Goldberg, J. H.: Actinomycin and nucleic acid function. Progr. Nuc. Acid Res. Mol. Biol. 3, 183–234 (1964).
Revel, M., Hiatt, H. H.: The stability of liver messenger RNA. Proc. nat. Acad. Sci. (Wash.) 51, 810–818 (1964).
Skalko, R. G., Morse, J. M. D.: The differential response of the early mouse embryo to actinomycin D treatment in vitro. Teratology 2, 47–54 (1969).
Taska, R. J., Hillman, N.: Effects of Actinomycin D and Cycloheximide on RNA and protein synthesis in cleavage stage mouse embryos. Nature (Lond.) 225, 1022–1025 (1970).
Tata, J. R.: Evidence for two DNA-dependent RNA polymerase activities in isolated rat liver nuclei. Biochim. biophys. Acta (Amst.) 87, 531 (1964).
Tuchmann-Duplessis, H.: The action of anti-tumor drugs on gestation and on embryogenesis. In: Teratology, pp. 75–86. A. Bertelli and L. Donati, ed. Amsterdam: Excerpta Medica Foundation 1969.
—, Mercier-Parot, L.: Sur l'activité tératogène chez le rat de l'actinomycine-D. C. R. Acad. Sci. (Paris) 247, 200 (1958).
——: Production de diverses malformations par administration d'actinomycine D à la ratte gestante. C.R. Soc. Biol. (Paris) 153, 386–391 (1959a).
——: A propos de l'action tératogène de l'actinomycine. C.R. Soc. Biol. (Paris) 153, 1697–1700 (1959b).
——: The teratogenic action of the antibiotic actinomycin D. In: CIBA Foundation Symposium on Congenital Malformations, p. 115. London: J. and A. Churchill (1960a).
——: A propos de l'action tératogène de l'actinomycine D essais de prévention par l'acide pantothémique. Rev. franç. Etud. clin. biol. 5, 823 (1960b).
Widnell, C. C., Tata, J. R.: Procedure for the isolation of enzymatically active rat liver nuclei. Biochem. J. 92, 313 (1964).
Wilson, J. G.: Effects of acute and chronic treatment with actinomycin D on pregnancy and the fetus in the rat. Harper Hosp. Bull. 24, 109 (1966).
Author information
Authors and Affiliations
Additional information
Supported by the Deutsche Forschungsgemeinschaft, SFB 29.
Rights and permissions
About this article
Cite this article
Köhler, E., Merker, H.J. Studies on the teratogenic phase specificity of actinomycin D in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 31–44 (1972). https://doi.org/10.1007/BF00505066
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00505066